PNC Financial Services Group
LAB icon

PNC Financial Services Group’s Standard BioTools LAB Stock Holding History

PNC Financial Services Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$80 Sell
108
-20
-16% -$15 ﹤0.01% 5303
2026
Q2 		$105 Hold
128
– – ﹤0.01% 5143
2026
Q1 		$118 Hold
128
– – ﹤0.01% 5086
2025
Q4 		$164 Hold
128
– – ﹤0.01% 5000
2025
Q3 		$166 Hold
128
– – ﹤0.01% 4956
2025
Q2 		$154 Hold
128
– – ﹤0.01% 4815
2025
Q1 		$138 Hold
128
– – ﹤0.01% 4802
2024
Q4 		$224 Hold
128
– – ﹤0.01% 4641
2024
Q3 		$247 Hold
128
– – ﹤0.01% 4657
2024
Q2 		$227 Hold
128
– – ﹤0.01% 4648
2024
Q1 		$347 Sell
128
-9
-7% -$22 ﹤0.01% 4536
2023
Q4 		$303 Buy
+137
New +$292 ﹤0.01% 4457
2021
Q1 		– Sell
-1,000
Closed -$6K – 4160
2020
Q4 		$6K Hold
1,000
– – ﹤0.01% 3680
2020
Q3 		$7K Buy
+1,000
New +$6.9K ﹤0.01% 3601
2017
Q2 		– Sell
-70
Closed – – 4192
2017
Q1 		$0 Hold
70
– – ﹤0.01% 4159
2016
Q4 		$1K Sell
70
-1,021
-94% -$6.41K ﹤0.01% 3925
2016
Q3 		$9K Sell
1,091
-184
-14% -$1.69K ﹤0.01% 3511
2016
Q2 		$12K Sell
1,275
-7
-0.5% -$66 ﹤0.01% 3467
2016
Q1 		$11K Buy
1,282
+1,060
+477% +$7.64K ﹤0.01% 3532
2015
Q4 		$2K Hold
222
– – ﹤0.01% 4171
2015
Q3 		$1K Sell
222
-187
-46% -$2.94K ﹤0.01% 4470
2015
Q2 		$10K Buy
409
+81
+25% +$2.56K ﹤0.01% 3794
2015
Q1 		$14K Buy
328
+13
+4% +$514 ﹤0.01% 3653
2014
Q4 		$11K Hold
315
– – ﹤0.01% 3348
2014
Q3 		$8K Hold
315
– – ﹤0.01% 3332
2014
Q2 		$9K Hold
315
– – ﹤0.01% 3155
2014
Q1 		$14K Buy
315
+84
+36% +$3.7K ﹤0.01% 2964
2013
Q4 		$9K Hold
231
– – ﹤0.01% 3014
2013
Q3 		$5K Hold
231
– – ﹤0.01% 3407
2013
Q2 		$4K Buy
+231
New +$4.05K ﹤0.01% 3312

Other funds holding LAB

Hollow Brook Wealth Management
Hollow Brook Wealth Management Katonah, New York $575M AUM 19.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
STALEY CAPITAL ADVISERS
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.67B AUM 20.47% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

PNC Financial Services Group's LAB Position: Q3 2026 in Review

PNC Financial Services Group reduced its Standard BioTools (LAB) stake by 16% in Q3 2026, selling an estimated $15 and leaving 108 shares worth $80. The position accounts for ﹤0.01% of the portfolio, ranked #5303.

PNC Financial Services Group first reported a position in LAB in Q2 2013 and has held it in 30 quarters since. The position peaked at $14K in Q1 2015. 33 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

  • PNC Financial Services Group held 108 shares of Standard BioTools worth $80 as of Q3 2026.
  • PNC Financial Services Group sold 20 Standard BioTools shares in Q3 2026, an estimated $15.
  • Standard BioTools made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #5303 holding.
  • PNC Financial Services Group first reported a position in Standard BioTools in Q2 2013 and has held it in 30 quarters since.
  • PNC Financial Services Group's Standard BioTools position peaked at $14K in Q1 2015.
  • 33 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.